Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Mission

Information Technology

Healthcare Technologies

Advanced Manufacturing and Industrial Technologies

Early Stage Partners was formed in 2001 with the belief that the Midwest would create and attract a significant number of companies that would be attractive early stage venture capital investments.

Since then, that belief has been borne out. The Midwest is in the midst of a surge of entrepreneurial energy that is generating high quality technologies and companies. We are pleased to work with the region’s leading entrepreneurs to provide financing, advice, and access to value-added networks.

With a track record of successful investing, ESP is now investing from Fund II.

Find Out More About ESP

News & Events

SironRX Completes Enrollment in Phase I Clinical Trial


April 17, 2013

SironRX is studying the wound healing capabilities of stromal-derived factor 1, a chemokine that recruits the body's own stem cells to sites of injury.

Telefonica Chooses TOA As Worldwide Partner


April 10, 2013

Major international telecommunications company chooses TOA over all competitors.

TOA Technologies Featured in Crain's Cleveland Business


February 28, 2013

Company caps high-growth 2012 by expanding to four continents.

ICN Issued Patent to Validate and Clear Coupons Electronically


February 27, 2013

With this newly issued patent, ICN is rolling out its Coupon Validation Center suite of products nationally